SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Daniel Acker — Bloomberg via Getty Images

39

Johnson & Johnson

JNJ

The 130-year old healthcare conglomerate sells everything from baby shampoo to surgical staples and cancer drugs (it also divested itself of Splenda, the artificial sweetener.) That diversification helped buoy giant J&J in 2015; the company’s strong pharmaceutical sales made up for the less impressive performances of its consumer and medical device divisions. The company’s revenues grew 2.6% in the US, but slid 5.7% worldwide in 2015, largely due to currency fluctuations and the sharp decline in sales of its Hepatitis C drug, Olysio.

CEO

Alex Gorsky

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

New Brunswick, NJ

Years on Fortune 500 List

22

Employees

127,100

Johnson & Johnson is also featured in these fortune lists
Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$70,074-5.7%
Profits ($M)$15,409-5.6%
Assets ($M)$133,411
Total Stockholder Equity ($M)$71,150
Market Value — as of March 31, 2016 ($M)$298,563
Profit Ratios
Profit as % of Revenues22.0%
Profits as % of Assets11.6%
Profits as % of Stockholder Equity21.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.48
EPS % Change (from 2014)-3.9%
EPS % Change (5 year annual rate)2.8%
EPS % Change (10 year annual rate)4.7%
Total Return
Total Return to Investors (2015)1.2%
Total Return to Investors (5 year, annualized)14.2%
Total Return to Investors (10 year, annualized)8.8%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Johnson & Johnson

GlaxoSmithKline Is Working on a Much Simpler HIV Treatment

It will reduce the number of drugs patients take.

Read More →
This New Tuberculosis Drug Could Change the World

A new weapon against a deadly infectious disease.

Read More →
Here's How Your Drugs May Get Priced in the Future

Democrats and Republicans are both promising fresh action on drug prices.

Read More →

Videos about Johnson & Johnson

3 business lessons from Microsoft's board nominee

We sat down with Sandra Peterson, chairwoman of Johnson & Johnson, at this year's Most Powerful Women Summit. Here are some lessons she learned over the years.

Read More →
How to become the World's Most Admired Company

Fortune released it's World's Most Admired Companies list, take a look at who made the top ten.

Read More →
How to look like you know what you're doing

These Fortune 500 executives explain how they stay on top of their busy schedule.

Read More →
7 tips on climbing the corporate ladder

Seven women executives from Fortune's Most Powerful Women community give their best career advice.

Read More →
How business execs make (and stick to) New Year's resolutions

Hate New Year's resolutions? These Most Powerful Women tell their tips and tricks to ring in the New Year the right way.

Read More →